Evaluation of 131I-anti-MIF mAb as a reporter for allograft rejection

Clinical Immunology

Volumn 139, Issue 1, 2011, Pages 40-47

  Liang, Ting ^a   Zhang, Chao ^a   Song, Jing ^a   Jiang, Shiqin ^a   Hao, Jing ^a   Hou, Guihua ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Allograft; ; Imaging; MIF; ; Rejection; ; Skin;

Indexed keywords

IMMUNOGLOBULIN G I 131; MACROPHAGE MIGRATION INHIBITORY FACTOR MONOCLONAL ANTIBODY I 131; RADIOISOTOPE; UNCLASSIFIED DRUG; MACROPHAGE MIGRATION INHIBITION FACTOR; MONOCLONAL ANTIBODY; RADIOACTIVE IODINE;

ACUTE GRAFT REJECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG DISTRIBUTION; ISOGRAFT; MOLECULAR IMAGING; MOUSE; NON INVASIVE MEASUREMENT; NONHUMAN; PATIENT MONITORING; PRIORITY JOURNAL; SKIN ALLOGRAFT; UPREGULATION; WHOLE BODY AUTORADIOGRAPHY; WHOLE BODY IMAGING; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; GRAFT REJECTION; IMMUNOLOGY; METABOLISM; PATHOLOGY; SKIN; SKIN TRANSPLANTATION; TISSUE DISTRIBUTION;

ANIMALS; ANTIBODIES, MONOCLONAL; GENE EXPRESSION REGULATION; GRAFT REJECTION; IODINE RADIOISOTOPES; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MICE; SKIN; SKIN TRANSPLANTATION; TISSUE DISTRIBUTION;

EID: 79953018419     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2010.12.017     Document Type: Article

References (30)

1. Isobe M., Southern J.F., Yazaki Y. Scintigraphic detection of early cardiac rejection by iodine 123-labeled monoclonal antibody directed against monomorphic determinant of major histocompatibility complex class II antigens. Am. Heart J. 1994, 127:1309-1317.
2. 111In antimyosin imaging in mouse heart allografts. Circulation 1991, 84:1246-1255.
3. McGhie A.I., Radovancevic B., Capek P., Moore W.H., Kasi L., Lamki L., Clubb F.J., Frazier O.H., Willerson J.T. Major histocompatibility complex class II antigen expression in rejecting cardiac allografts: detection using in vivo imaging with radiolabeled monoclonal antibody. Circulation 1997, 96:1605-1611.
4. Kown M.H., Jahncke C.L., Lijkwan M.A., Koransky M.L., Mari C., Berry G.J., Blankenberg F.G., Strauss H.W., Robbins R.C. The use of (99m) technetium-labeled MCP-1 to assess graft coronary artery disease in rat cardiac allografts. J. Heart Lung Transplant. 2002, 21:1009-1015.
5. David J.R. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc. Natl Acad. Sci. USA 1966, 56:72-77.
6. Bloom B.R., Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 1966, 153:80-82.
7. Bernhagen J., Bacher M., Calandra T., Metz C.N., Doty S.B., Donnelly T., Bucala R. An essential role for macrophage migration inhibitory factor in the tuberculin delayed type hypersensitivity reaction. J. Exp. Med. 1996, 183:277-282.
8. Le Meur Y., Jose M.D., Mu W., Atkins R.C., Chadban S.J. Macrophage colony-stimulating factor expression and macrophage accumulation in renal allograft rejection. Transplantation 2002, 73:1318-1324.
9. Mikulowska A., Metz C.N., Bucala R., Holmdahl R. Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. J. Immunol. 1997, 158:5514-5517.
10. Santos L.L., Hall P., Metz C.N., Bucala R., Morand E.F. Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids. Clin. Exp. Immunol. 2001, 123:309-314.
11. Ichiyama H., Onodera S., Nishihira J., Ishibashi T., Nakayama T., Minami A., Yasuda K., Tohyama H. Inhibition of joint inflammation and destruction induced by anti-type II collagen antibody/lipopolysaccharide (LPS)-induced arthritis in mice due to deletion of macrophage migration inhibitory factor (MIF). Cytokine 2004, 26:187-194.
12. Donnelly S.C., Haslett C., Reid P.T., Grant I.S., Wallace W.A., Metz C.N., Bruce L.J., Bucala R. Regulatory role for macrophage migration inhibitory factor in acute respiratory distress syndrome. Nat. Med. 1997, 3:320-323.
13. Lan H.Y., Yang N., Nikolic-Paterson D.J., Yu X.Q., Mu W., Isbel N.M., Metz C.N., Bucala R., Atkins R.C. Expression of macrophage migration inhibitory factor in human glomerulonephritis. Kidney Int. 2000, 57:499-509.
14. Selvi E., Tripodi S.A., Catenaccio M., Lorenzini S., Chindamo D., Manganelli S., Romagnoli R., Ietta F., Paulesu L., Miracco C., Cintorino M., Marcolongo R. Expression of macrophage migration inhibitory factor in diffuse systemic sclerosis. Ann. Rheum. Dis. 2003, 62:460-464.
15. Lo J.W., Leung A.Y., Huang X.R., Lie A.K., Metz C., Bucala R., Liang R., Lan H.Y. Macrophage migration inhibitory factor (MIF) expression in acute graft-versus-host disease (GVHD) in allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2002, 30:375-380.
16. Brown F.G., Nikolic-Paterson D.J., Metz C., Bucala R., Atkins R.C., Lan H.Y. Up-regulation of macrophage migration inhibitory factor in acute renal allograft rejection in the rat. Clin Exp Immunol 1999, 118:329-336.
17. Toubai T., Tanaka J., Nishihira J., Ohkawara T., Hirate D., Kondo N., Tone S., Shono Y., Ibata M., Sugita J., Kato N., Miura Y., Iwao N., Ota S., Imamura M. Effect of macrophage migration inhibitory factor (MIF) on acute graft-versus-host disease in a murine model of allogeneic stem cell transplantation. Transpl. Immunol. 2006, 16:117-124.
18. Valujskikh A., Matesic D., Gilliam A., Anthony D., Haqqi T.M., Heeger P.S. T cells reactive to a single immunodominant self-restricted allopeptide. J. Clin. Invest. 1998, 101:1398-1407.
19. Valujskikh A., Matesic D., Heeger P.S. Characterization and manipulation of T cell immunity to skin grafts expressing a transgenic minor antigen. Transplantation 1999, 68:1029-1036.
20. Valujskikh A., Heeger P.S. CD4+ T cells responsive through the indirect pathway can mediate skin graft rejection in the absence of interferongamma. Transplantation 2000, 69:1016-1019.
21. Zhang C., Hou G., Liang T., Song J., Qu L., Chen F., Xu J., Wang D., Han J. A prospective study of macrophage migration inhibitory factor as a marker of inflammatory detection. J. Cell. Mol. Med. 2009, 13:4077-4083.
22. Sirak J., Orosz C.G., Wakely E., VanBuskirk A.M. Alloreactive delayed-type hypersensitivity in graft recipients: complexity of responses and divergence from acute rejection. Transplantation 1997, 63:1300-1307.
23. Wyburn K.R., Jose M.D., Wu H., Atkins R.C., Chadban S.J. The role of macrophages in allograft rejection. Transplantation 2005, 80:1641-1647.
24. Calandra T., Bernhagen J., Metz C.N., Spiegel L.A., Bacher M., Donnelly T., Cerami A., Bucala R. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995, 377:68-71.
25. Bacher M., Metz C.N., Calandra T., Mayer K., Chesney J., Lohoff M., Gemsa D., Donnelly T., Bucala R. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation. Proc. Natl Acad. Sci. USA 1996, 93:7849-7854.
26. Lan H.Y., Yang N., Brown F.G., Isbel N.M., Nikolic-Paterson D.J., Mu W., Metz C.N., Bacher M., Atkins R.C., Bucala R. Macrophage migration inhibitory factor expression in human renal allograft rejection. Transplantation 1998, 66:1465-1471.
27. Brown F.G., Nikolic-Paterson D.J., Chadban S.J., Dowling J., Jose M., Metz C.N., Bucala R., Atkins R.C. Urine macrophage migration inhibitory factor concentrations as a diagnostic tool in human renal allograft rejection. Transplantation 2001, 71:1777-1783.
28. Jose M.D., David J.R., Atkins R.C., Chadban S.J. Blockade of macrophage migration inhibitory factor does not prevent acute renal allograft rejection. Am. J. Transplant. 2003, 3:1099-1106.
29. Demir Y., Chen Y., Metz C., Renz H., Heeger P.S. Cardiac allograft rejection in the absence of macrophage migration inhibitory factor. Transplantation 2003, 76:244-247.
30. Fukuyama S., Yoshino I., Yamaguchi M., Osoegawa A., Kameyama T., Tagawa T., Maehara Y. Blockage of the macrophage migration inhibitory factor expression by short interference RNA inhibited the rejection of an allogeneic tracheal graft. Transpl. Int. 2005, 18:1203-1209.